Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 26, 2018 - Issue 2
Submit an article Journal homepage
210
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Treatment of Serpiginous Choroiditis with Chlorambucil: A Report of 17 Patients

Nazanin EbrahimiadibMassachusetts Eye Research and Surgery Institute, Waltham, Massachusetts, USA;Ocular Immunology and Uveitis Foundation, Weston, Massachusetts, USA
, MD,
Bobeck S. ModjtahediRetina Service, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA
, MD,
Samaneh DavoudiRetina Service, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA
, MD &
C. Stephen FosterMassachusetts Eye Research and Surgery Institute, Waltham, Massachusetts, USA;Ocular Immunology and Uveitis Foundation, Weston, Massachusetts, USA;Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USACorrespondence[email protected]
, MD
Pages 228-238 | Received 19 Apr 2016, Accepted 15 Jul 2016, Published online: 18 Oct 2016

REFERENCES

  • Laatikainen L, Erkkilä H. Serpiginous choroiditis. British J Ophthalmol. 1974;58:777–783.
  • Franceschetti A. A curious affection of the fundus oculi: helicoid peripapillar chorioretinal degeneration. Its relation to pigmentary paravenous chorioretinal degeneration. Doc Ophthalmol. 1962;16:81–110.
  • Akpek EK, Ilhan-Sarac O. New treatments for serpiginous choroiditis. Curr Opin Ophthalmol. 2003;14:128–131.
  • Abrez H, Biswas J, Sudharshan S. Clinical profile, treatment, and visual outcome of serpiginous choroiditis. Ocul Immunol Inflamm. 2007;15:325–335.
  • Hamilton AM, Bird AC. Geographical choroidopathy. Br J Ophthalmol. 1974;58:784–797.
  • Toniolo J, Hall AJ, Sims J, et al. Retrospective analysis of the natural history and management of serpiginous choroiditis in Australia and New Zealand. Clin Exp Ophthalmol. 2014;42:656–664.
  • Weiss H, Annesley WH Jr, Shields JA, et al. The clinical course of serpiginous choroidopathy. Am J Ophthalmol. 1979;87:133–142.
  • Khanamiri S, Soltysinska E, Jepps TA, et al. Contribution of Kv7 channels to basal coronary flow and active response to ischemia. Hypertension. 2013;62:1090–1097.
  • Wu JS, Lewis H, Fine SL, et al. Clinicopathologic findings in a patient with serpiginous choroiditis and treated choroidal neovascularization. Retina. 1989;9:292–301.
  • Lim WK, Buggage RR, Nussenblatt RB. Serpiginous choroiditis. Surv Ophthalmol. 2005;50:231–244.
  • Laatikainen L, Erkkila H. A follow-up study on serpiginous choroiditis. Acta Ophthalmol (Copenh). 1981;59:707–718.
  • Nazari Khanamiri H, Rao NA. Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis. Surv Ophthalmol. 2013;58:203–232.
  • Sahin OG. Long-term cyclophosphamide treatment in a case with serpiginous choroiditis. Case Rep Ophthalmol. 2010;1:71–76.
  • Secchi AG, Tognon MS, Maselli C. Cyclosporine-A in the treatment of serpiginous choroiditis. Int Ophthalmol. 1990;14:395–399.
  • Akpek EK, Baltatzis S, Yang J, et al. Long-term immunosuppressive treatment of serpiginous choroiditis. Ocul Immunol Inflamm. 2001;9:153–167.
  • Akpek EK, Jabs DA, Tessler HH, et al. Successful treatment of serpiginous choroiditis with alkylating agents. Ophthalmology. 2002;109:1506–1513.
  • Araujo AA, Wells AP, Dick AD, et al. Early treatment with cyclosporin in serpiginous choroidopathy maintains remission and good visual outcome. Br J Ophthalmol. 2000;84:979–982.
  • Hooper PL, Kaplan HJ. Triple agent immunosuppression in serpiginous choroiditis. Ophthalmology. 1991;98:944–952.
  • Vianna RN, Ozdal PC, Deschenes J, et al. Combination of azathioprine and corticosteroids in the treatment of serpiginous choroiditis. CJO/JCO. 2006;41:183–189.
  • Venkatesh P, Gogia V, Gupta S, et al. Pulse cyclophosphamide therapy in the management of patients with macular serpiginous choroidopathy. Indian J Ophthalmol. 2015;63:318–322.
  • Mangerich A, Debiak M, Birtel M, et al. Sulfur and nitrogen mustards induce characteristic poly(ADP-ribosyl)ation responses in HaCaT keratinocytes with distinctive cellular consequences. Toxicol Lett. 2016;244:56–71.
  • Goldstein DA, Fontanilla FA, Kaul S, et al. Long-term follow-up of patients treated with short-term high-dose chlorambucil for sight-threatening ocular inflammation. Ophthalmology. 2002;109:370–377.
  • Miserocchi E, Baltatzis S, Ekong A, et al. Efficacy and safety of chlorambucil in intractable noninfectious uveitis: the Massachusetts Eye and Ear Infirmary experience. Ophthal-mology. 2002;109:137–142.
  • Grupe WE. Chlorambucil in steroid-dependent nephrotic syndrome. J Pediatr. 1973;82:598–606.
  • Richter P, Calamera JC, Morgenfeld MC, et al. Effect of chlorambucil on spermatogenesis in the human with malignant lymphoma. Cancer. 1970;25:1026–1030.
  • Callis L, Nieto J, Vila A, et al. Chlorambucil treatment in minimal lesion nephrotic syndrome: a reappraisal of its gonadal toxicity. J Pediatr. 1980;97:653–656.
  • Kahn MF, Arlet J, Bloch-Michel H, et al. [Acute leukaemias after treatment using cytotoxic agents for rheumatological purpose. 19 cases among 2006 patients] (author’s transl.). La Nouvelle Presse Medicale. 1979;8:1393–1397.
  • Birnbaum AD, Oh F, Sahin O, et al. Chlorambucil and malignancy. Ophthalmology. 2010;117:1466–1466.
  • Lampariello DA. Geographic (serpiginous) choroiditis. J Am Optom Assoc. 1992;63:112–116.
  • Karagiannis DA, Sampat FV, Dowler J. Serpiginous choroidopathy with bilateral foveal sparing and good visual acuity after 18 years of disease. Retina. 2007;27:989–990.
  • Christmas NJ, Oh KT, Oh DM, et al. Long-term follow-up of patients with serpiginous choroiditis. Retina. 2002;22:550–556.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.